Maria Häggblad

1.2k total citations
12 papers, 175 citations indexed

About

Maria Häggblad is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Maria Häggblad has authored 12 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Maria Häggblad's work include ATP Synthase and ATPases Research (3 papers), Biochemical and Molecular Research (3 papers) and Enzyme function and inhibition (2 papers). Maria Häggblad is often cited by papers focused on ATP Synthase and ATPases Research (3 papers), Biochemical and Molecular Research (3 papers) and Enzyme function and inhibition (2 papers). Maria Häggblad collaborates with scholars based in Sweden, Spain and Denmark. Maria Häggblad's co-authors include Sabin Llona‐Minguez, Ann‐Sofie Jemth, Thomas Helleday, Olga Loseva, Elisée Wiita, Evert Homan, Robert Gustafsson, Pål Stenmark, Katarina Färnegårdh and Nina Gustafsson and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and PLoS Biology.

In The Last Decade

Maria Häggblad

11 papers receiving 175 citations

Peers

Maria Häggblad
Becky Pinjou Tsai United States
Stijn Vereecke Belgium
Olivia W. Lee United States
Renaud Vatrinet Italy
Shabana Vohra United Kingdom
Shaunna Beedie United States
Anna Di Matteo Italy
Joshua Beri United States
Neha Rohatgi Singapore
Anne Steinø United States
Becky Pinjou Tsai United States
Maria Häggblad
Citations per year, relative to Maria Häggblad Maria Häggblad (= 1×) peers Becky Pinjou Tsai

Countries citing papers authored by Maria Häggblad

Since Specialization
Citations

This map shows the geographic impact of Maria Häggblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Häggblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Häggblad more than expected).

Fields of papers citing papers by Maria Häggblad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Häggblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Häggblad. The network helps show where Maria Häggblad may publish in the future.

Co-authorship network of co-authors of Maria Häggblad

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Häggblad. A scholar is included among the top collaborators of Maria Häggblad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Häggblad. Maria Häggblad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Li, Xuexin, Ivó H. Hernández, Seda Koyuncu, et al.. (2024). The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ. EBioMedicine. 103. 105124–105124.
2.
Colicchia, Valeria, Maria Häggblad, Xuexin Li, et al.. (2022). New regulators of the tetracycline‐inducible gene expression system identified by chemical and genetic screens. FEBS Open Bio. 12(10). 1896–1908. 2 indexed citations
3.
Kanellis, Dimitris C., Patrycja Michalska, Maria Häggblad, et al.. (2021). A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors. PLoS Biology. 19(5). e3001263–e3001263. 5 indexed citations
4.
Hühn, Daniela, Silvana Mourón, Catherine S. Hansel, et al.. (2021). Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. Molecular Oncology. 16(1). 148–165. 19 indexed citations
5.
Carreras‐Puigvert, Jordi, Maria Häggblad, Bo Lundgren, et al.. (2020). High content drug screening for Fanconi anemia therapeutics. Orphanet Journal of Rare Diseases. 15(1). 170–170. 1 indexed citations
6.
Häggblad, Maria, Lars Bräutigam, Vanesa Lafarga, et al.. (2018). A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats. Cell chemical biology. 26(2). 235–243.e5. 14 indexed citations
7.
Llona‐Minguez, Sabin, Maria Häggblad, Ulf Märtens, et al.. (2017). Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems. Bioorganic & Medicinal Chemistry Letters. 27(15). 3219–3225. 5 indexed citations
8.
Llona‐Minguez, Sabin, Andreas Höglund, Elisée Wiita, et al.. (2017). Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1. Journal of Medicinal Chemistry. 60(5). 2148–2154. 18 indexed citations
9.
Llona‐Minguez, Sabin, Maria Häggblad, Ulf Märtens, et al.. (2017). Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines. Bioorganic & Medicinal Chemistry Letters. 27(16). 3897–3904. 6 indexed citations
10.
Gustafsson, Robert, Ann‐Sofie Jemth, Nina Gustafsson, et al.. (2016). Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor. Cancer Research. 77(4). 937–948. 71 indexed citations
11.
Schmidt, Linnéa, Sathishkumar Baskaran, Patrik Johansson, et al.. (2016). Case-specific potentiation of glioblastoma drugs by pterostilbene. Oncotarget. 7(45). 73200–73215. 15 indexed citations
12.
Schmidt, Linnéa, Naser Monsefi, Mats Olsson, et al.. (2013). Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions. Neuro-Oncology. 15(11). 1469–1478. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Becky Pinjou Tsai Breakdown of academic impact, for papers by Stijn Vereecke Breakdown of academic impact, for papers by Olivia W. Lee Breakdown of academic impact, for papers by Renaud Vatrinet Breakdown of academic impact, for papers by Shabana Vohra Breakdown of academic impact, for papers by Shaunna Beedie Breakdown of academic impact, for papers by Anna Di Matteo Breakdown of academic impact, for papers by Joshua Beri Breakdown of academic impact, for papers by Neha Rohatgi Breakdown of academic impact, for papers by Anne Steinø
Rankless by CCL
2026